| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |